Literature DB >> 12153905

Continuous combined hormone replacement therapy and endometrial hyperplasia.

David F Archer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12153905      PMCID： PMC1123759          DOI： 10.1136/bmj.325.7358.231

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Is progestogen supplementation of ERT really necessary?

Authors:  Frederick Naftolin; David Silver
Journal:  Menopause       Date:  2002 Jan-Feb       Impact factor: 2.953

2.  Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate.

Authors:  J H Pickar; I Yeh; J E Wheeler; M F Cunnane; L Speroff
Journal:  Fertil Steril       Date:  2001-07       Impact factor: 7.329

3.  Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.

Authors:  S A Beresford; N S Weiss; L F Voigt; B McKnight
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

4.  Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease. Postmenopausal Estrogen/Progestin Interventions Trial.

Authors:  R D Langer; J J Pierce; K A O'Hanlan; S R Johnson; M A Espeland; J F Trabal; V M Barnabei; M J Merino; R E Scully
Journal:  N Engl J Med       Date:  1997-12-18       Impact factor: 91.245

5.  Risk of endometrial cancer following estrogen replacement with and without progestins.

Authors:  E Weiderpass; H O Adami; J A Baron; C Magnusson; R Bergström; A Lindgren; N Correia; I Persson
Journal:  J Natl Cancer Inst       Date:  1999-07-07       Impact factor: 13.506

Review 6.  Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding.

Authors:  A Lethaby; C Farquhar; A Sarkis; H Roberts; R Jepson; D Barlow
Journal:  Cochrane Database Syst Rev       Date:  2000

7.  Continuous combined hormone replacement therapy and risk of endometrial cancer.

Authors:  D A Hill; N S Weiss; S A Beresford; L F Voigt; J R Daling; J L Stanford; S Self
Journal:  Am J Obstet Gynecol       Date:  2000-12       Impact factor: 8.661

8.  Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium.

Authors:  M I Whitehead; P T Townsend; J Pryse-Davies; T A Ryder; R J King
Journal:  N Engl J Med       Date:  1981-12-31       Impact factor: 91.245

9.  Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

Authors: 
Journal:  JAMA       Date:  1996-02-07       Impact factor: 56.272

10.  Effect on endometrium of long term treatment with continuous combined oestrogen-progestogen replacement therapy: follow up study.

Authors:  Michael Wells; David W Sturdee; David H Barlow; Lian G Ulrich; Karen O'Brien; Michael J Campbell; Martin P Vessey; Anthony J Bragg
Journal:  BMJ       Date:  2002-08-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.